Resources
Big Molecule Watch
- FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and Biosimilars May 3, 2024 Julie Tibbets|Daniel Farraye
- Accord BioPharma, Inc. Announces FDA Approval of HERCESSI (trastuzumab-strf) May 2, 2024 Gabriella Montes
- PTAB Issues Final Written Decisions Finding Claims of Recombinant Lentiviral Vector Patents Valid May 1, 2024 Lihui Bai
- Biosimilar Approval Updates in Europe and China April 30, 2024 Kristin Beale
- GSK Sues Pfizer, Pharmacia & Upjohn & BioNTech for Infringing mRNA Vaccine Patents April 29, 2024 Elaine Blais
- Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR April 29, 2024 Timothy Beavers|Natasha Daughtrey
- Alvotech Announces Positive Topline Results From Confirmatory Clinical Study for its Proposed Golimumab Biosimilar April 26, 2024 Timothy Beavers
- FDA Approval of Alvotech/Teva Ustekinumab Biosimilar April 23, 2024 Seth Manilove
- DOJ Files False Claims Act Complaint Against Regeneron, Alleging Fraudulent Eylea Drug Pricing April 22, 2024 Grace Truong
- Federal Circuit Dismisses Appeals in Regeneron v. Mylan (Aflibercept) BPCIA Litigation April 22, 2024 Grace Truong
BioPharma Reporter
- GLP-1R agonists clinical trial design must be improved to ease concerns May 2, 2024
- Adare expands global high potency handling capabilities May 2, 2024
- Ennogen secures £30m credit facility to fuel expansion May 2, 2024
- From banking to biotech - Renée Aguiar-Lucander's unique path in science May 1, 2024
- Pfizer heralds “paradigm shift” in hemophilia B gene therapy with FDA approval April 30, 2024
- Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on oligonucleotides? April 30, 2024
- Tolerizing vaccines for autoimmune diseases tempt BMS into $1.8bn collaboration April 30, 2024
- SynOx takes rare tumour treatment to phase 3 with $75m Series B April 29, 2024
- Bristol Myers Squibb enlists Cellares amid industry manufacturing “land grab” April 29, 2024
- Jetted resin revolution: Purolite's biopharma breakthroughs April 26, 2024